H.C. Wainwright launched its coverage of eczema drug developer Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy recommendation and an $11 per share target on Thursday, despite an over 38% drop ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

After hours: January 29 at 6:19:11 PM EST Loading Chart for CRVS ...

The First Heretic is set 50 years before the Heresy. Lorgar and the Word Bearers worship the Emperor as a god, a devotion which he rejects entirely. Lorgar is gripped by despair, but his adopted ...

OBIO Orchestra BioMed Holdings, Inc.